Association of the lipoprotein lipase gene Ser447Ter polymorphism with hypertension and blood pressure variation: evidence from an updated meta-analysis

2017 ◽  
Vol 39 (7) ◽  
pp. 655-664
Author(s):  
June Wang ◽  
Shenlin Du ◽  
Jiamin Wang ◽  
Man Zhu ◽  
Xue Wen ◽  
...  
2002 ◽  
Vol 20 (11) ◽  
pp. 2199-2204 ◽  
Author(s):  
Yan-Qing Ma ◽  
G Neil Thomas ◽  
Julian AJH Critchley ◽  
Zoe SK Lee ◽  
Juliana CN Chan ◽  
...  

2007 ◽  
Vol 23 (3) ◽  
pp. 161-166 ◽  
Author(s):  
Penbe Cagatay ◽  
Belgin Susleyici-Duman ◽  
Cavlan Ciftci

Our aim was to determine whether lipoprotein lipase gene PvuII polymorphism can be considered as an independent risk factor for coronary artery disease (CAD) by conducting a meta-analysis of all available published trials, including our own study. In 7 seperate studies, 3289 subjects were screened for this substitution; meta-analysis included only some of these individuals. Among the 7 studies, 6 were performed on white subjects, whereas 1 was on patients with Saudi Arabic descent.Subgroup analysis indicated that individuals with PvuII substitution does not have an increased risk for CAD. The LPL-PvuII genotype and allele frequency distributions did not differ significantly between CAD patients and healthy controls. There was no difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. However, no significant differences in lipid variables (triglyceride and HDL-cholesterol) were determined for the PvuII polymorphisms in the patients with CAD. No significant differences were found in serum triglyceride and HDL-cholesterol levels for LPL-PvuII genotypes when the control and CAD groups were pooled. In conclusion, LPL-Pvu II polymorphism cannot be used as independent genetic risk factor for CAD.


2004 ◽  
Vol 115 (1) ◽  
pp. 8-12 ◽  
Author(s):  
Wenjie Yang ◽  
Jianfeng Huang ◽  
Dongliang Ge ◽  
Cailiang Yao ◽  
Xiufang Duan ◽  
...  

2004 ◽  
Vol 27 (6) ◽  
pp. 373-378 ◽  
Author(s):  
Biao LI ◽  
Dongliang GE ◽  
Yuelan WANG ◽  
Weiyan ZHAO ◽  
Xiaoyang ZHOU ◽  
...  

2008 ◽  
Vol 168 (11) ◽  
pp. 1233-1246 ◽  
Author(s):  
G. S. Sagoo ◽  
I. Tatt ◽  
G. Salanti ◽  
A. S. Butterworth ◽  
N. Sarwar ◽  
...  

Author(s):  
Xiaojie Jin ◽  
Yi Lu ◽  
Peng Zhao

Background: Cognitive impairment is very common in patients with hypertension, it’s necessary to conduct a meta-analysis to evaluate the association of cognitive function and blood pressure variability in patients with hypertension, to provide insights into the clinical management of hypertension and cognitive impairment. Methods: We searched PubMed et al databases for the case-control studies on the association between blood pressure variability and cognitive function up to July 15, 2021. Two researchers independently screened the literature and retrieved the data. RevMan 5.3 was used for data meta-analysis Results: A total of 13 studies involving 2754 patients were included. Meta-analysis indicated that 24-hour systolic [MD= 3.54, 95% CI (2.48, 4.60)] and diastolic [MD=2.43, 95%CI (1.55, 3.31)] blood pressure variation coefficient in the CI group were significantly higher than that of no CI group (all P<0.05). Standard deviation of systolic [MD=2.20, 95% CI (0.27, 4.13)] and diastolic [MD=1.79, 95% CI (0.80, 2.79)] blood pressure variation in the CI group were significantly higher than that of no CI group (all P<0.05). Mean systolic [MD=3.73, 95% CI (0.92, 6.53)]and diastolic [MD = 5.41, 95% CI (0.42, 10.40)] blood pressure variation in the CI group were significantly higher than that of no CI group (all P<0.05). There were no statistically significant differences in the morning peak systolic [MD=7.85,95% CI (-1.30,17.01)] and diastolic [MD=4.44,95% CI (-6.00, 14.89)] blood pressure drop between the CI group and no CI group(all P>0.05). Conclusion: Cognitive impairment in hypertensive patients is closely associated with increased blood pressure variability, and clinical medical staff should pay attention to the management of blood pressure variability in hypertensive patients to reduce the development of cognitive impairments.


Sign in / Sign up

Export Citation Format

Share Document